Literature DB >> 30353293

A specific scoring system able to predict the efficacy of the therapy for bladder cancer: why not?

Fabrizio Dal Moro1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30353293     DOI： 10.1007/s00345-018-2533-y

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  4 in total

Review 1.  Urinary markers in the everyday diagnosis of bladder cancer.

Authors:  Fabrizio Dal Moro; Claudio Valotto; Andrea Guttilla; Filiberto Zattoni
Journal:  Urologia       Date:  2013-11-29

2.  Effect of hypertension on outcomes of high-risk patients after BCG-treated bladder cancer: a single-institution long follow-up cohort study.

Authors:  Fabrizio Dal Moro; Alberto Bovo; Alessandro Crestani; Roberto Vettor; Marina P Gardiman; Filiberto Zattoni
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

3.  Does age really matter in the choice of treatment for bladder cancer?

Authors:  F Dal Moro; A Rossi; F Zattoni
Journal:  Br J Cancer       Date:  2013-05-14       Impact factor: 7.640

Review 4.  Molecular markers in bladder cancer.

Authors:  Francesco Soria; Laura-Maria Krabbe; Tilman Todenhöfer; Jakub Dobruch; Anirban P Mitra; Brant A Inman; Kilian M Gust; Yair Lotan; Shahrokh F Shariat
Journal:  World J Urol       Date:  2018-09-26       Impact factor: 4.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.